Feedback
  • Account Access
  • Contact Us

    Advisor Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Investor & Website Support
    888-843-7824
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

  • Advisor Log In

Hartford Healthcare HLS Fund

Explore Another ETFs

Objective

Seeks long-term capital appreciation.

Overview

A stock fund that invests in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

Effective 12/31/17, this Fund is closed to certain qualified pension and retirement plans.  For more information, please refer to the fund's statutory prospectus.

More About Healthcare HLS Fund 

Performance

Performance (%)
% (as of 9/30/2018)
Average Annual Total Returns % (as of 9/30/2018)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS  IA 15.32 13.65 12.89 15.86 14.91 12.68
Benchmark 18.03 19.95 15.58 15.89 14.66 ---
Morningstar Health Category 19.12 19.63 12.72 14.66 14.81 ---
Performance (%)
% (as of 9/30/2018)
Average Annual Total Returns % (as of 9/30/2018)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare HLS  IA 15.32 13.65 12.89 15.86 14.91 12.68
Benchmark 18.03 19.95 15.58 15.89 14.66 ---
Morningstar Health Category 19.12 19.63 12.72 14.66 14.81 ---
SI = Since Inception. Fund Inception: 05/01/2000
Operating Expenses:   Net  0.90% |  Gross  0.90%

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Prior to 4/1/2016, the Fund's benchmark was the S&P North American Health Care Sector Index.

Calendar Year Returns (%)
Fund Benchmark
2017 22.26 22.47
2016 -8.39 -2.05
2015 13.21 7.41
2014 27.39 24.79
2013 51.84 42.19
2012 20.62 18.35
2011 8.54 11.88
2010 7.10 5.20
2009 22.72 20.76
2008 -25.56 -23.76

Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.

Characteristics Holdings are subject to change. Percentages may be rounded.

Statistics
As of Date 9/30/2018
Net Assets $350 million
# of Holdings 111
% in Equities 96
% in Foreign Equities 12
Beta (3 year) 1.13
R Squared (3 year) 0.85
Standard Deviation 14.48%
Turnover (9/30/2018) 26%
Holdings Characteristics
(as of 9/30/2018)
Fund S&P Composite 1500 Health Care Index
Price/Earnings 52.5x 16.8x
Price/Book 5.0x 4.8x
EPS Growth Rate 17.8% 11.4%
Return on Equity -2.4% 20.6%
Asset Weighted Market Cap (billions) $58.5 $126.1
Median Market Cap (billions) $5.6 $5.3

Subsector Exposure

(as of 9/30/2018)
label currentpercentage
Medical Technology 26
Health Care Services 23
Biopharma Large Cap 21
Biopharma Mid Cap 20
Biopharma Small Cap 11
(as of 6/30/2018)
label currentpercentage
Medical Technology 27
Health Care Services 22
Biopharma Large Cap 19
Biopharma Mid Cap 20
Biopharma Small Cap 12
Based on sub-adviser's classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.

Top Holdings

(as of 9/30/2018)
label percentageholding
UnitedHealth Group, Inc. 6.09
Medtronic plc 3.93
Abbott Laboratories 3.89
Bristol-Myers Squibb Co. 3.83
Boston Scientific Corp. 3.45
Allergan plc 3.14
Eli Lilly & Co. 2.83
Thermo Fisher Scientific, Inc. 2.81
Anthem, Inc. 2.56
HCA Healthcare, Inc. 2.48
Total Portfolio % 35.01
(as of 6/30/2018)
label percentageholding
UnitedHealth Group, Inc. 6.16
Medtronic plc 4.35
Bristol-Myers Squibb Co. 3.74
Boston Scientific Corp. 3.22
Allergan plc 3.02
Stryker Corp. 2.68
Loxo Oncology, Inc. 2.64
Thermo Fisher Scientific, Inc. 2.58
Eli Lilly & Co. 2.47
AstraZeneca plc 2.21
Total Portfolio % 33.07
Market Cap Distribution %
(as of 9/30/2018)
Less than $2 billion 13
$2 billion - $5 billion 8
$5 billion - $10 billion 11
Greater than $10 billion 68
Not Classified 0
Fund Essentials
Inception Date 05/01/2000
Symbol HIAHX
CUSIP 416528719
Fund Number 2055

Insights

pdf

Client Conversations: HSAs: 1 Account, 3 Tax Benefits 

Thu Feb 15 12:00:00 EST 2018
Have a health savings account, but not contributing to it? You could be missing out.
pdf

Client Conversations: Why You Should Care About Medicare 

Fri Oct 13 12:00:00 EDT 2017
Medicare can be tough to understand. It doesn’t have to be.

Literature

Fund Literature

Select All

Expanded Commentary

06/30/2018 | pdf

Max 100

Summary Prospectus

05/01/2018 | pdf

Available For
Download Only

Semi Annual Report

06/30/2018 | pdf

Available For
Download Only

Statutory Prospectus

05/01/2018 | pdf

Available For
Download Only

Annual Report

12/31/2017 | pdf

Available For
Download Only

SAI

05/01/2018 | pdf

Available For
Download Only

Financial Professionals:

Log in to order forms and literature and manage your subscriptions.

Important Risks: Investing involves risk, including the possible loss of principal. There is no guarantee a fund will achieve its stated objective. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political and economic developments. These risks may be greater for investments in emerging markets. • Small- and mid-cap securities can have greater risk and volatility than large-cap securities.

Hartford HLS Funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA. Advisory services are provided by Hartford Funds Management Company, LLC (HFMC). The Funds are sub-advised by Wellington Management Company LLP, which is not affiliated with HFD or HFMC.

208483    206871